Reference no: EM133858509
Question 1. In the case of antituberculous treatment toxicity, how high should the serum glutamic pyruvate transaminase (SGPT) rise before we should stop treatment?
Question 2. After starting antituberculous treatment, when is the fever expected to subside and the erythrocyte sedimentation rate (ESR) to return to normal?
Question 3. What are the indications of steroids in the treatment of tuberculosis?
Question 4. I am a final-year medical student in India, where tuberculosis in all forms is one of the most common diseases with which we deal. I read that you feel there is no indication for steroids in tuberculosis. Is it not reasonable
Question 5. What dosage of steroids and duration of treatment should be given to patients with idiopathic pulmonary fibrosis? What are the new drugs, their recommended dosage and duration of treatment?
Question 6. What is the poor prognostic factor in cryptogenic fibrosis: fibrosis or concomitant connective tissue disorder?
Question 7. Are wheezes present in extrinsic allergic alveolitis?
Question 8. Is the measurement of chest expansion with a tape a useful physical examination to indicate the severity of emphysema?
Question 9. In asbestos-related pleural disease (pleural plaques and mesothelioma), how do asbestos fibres get to the pleural space?
Question 10. How do you differentiate clinically between thickened pleura and pleural effusion?